Appointment of Adviser

 

TIDMPYN 
 
 
Phynova Group PLC 
17 June 2009 
 
? 
17 June 2009 
 
 
Phynova Group plc 
("Phynova" or "the Company") 
 
 
Appointment of adviser 
 
 
The Company announces that earlier today London & Pacific Healthcare, Inc. 
released an announcement which made reference to Phynova and City & Westminster 
Corporate Finance LLP ("C&W"), the text of which is set out below. The Company 
has retained C&W to advise on financial and strategic alternatives for 
development, acquisition targets and growth. 
 
 
"London & Pacific Healthcare Retained by London Firm to Develop Premier 
Botanical Medicines and Functional Foods Strategy 
 
 
EL SEGUNDO, CA - June 16, 2009 - LONDON & PACIFIC HEALTHCARE, INC. (PINK SHEETS: 
LDPH) (FRANKFURT: EGU) ("London & Pacific" or the "Company"), the international 
healthcare development specialist, today announced it has been retained by 
London-based corporate finance advisor, City & Westminster Corporate Finance LLP 
("C&W"), to provide specialized advisory services. 
 
 
London & Pacific will provide strategic development and advisory services to C&W 
in regards to the consolidation of functional foods and botanical medicines on a 
global scale. C&W will be advising Phynova Group PLC ("Phynova"), a leading 
expert in botanical pharmaceutical development, on its financial and strategic 
alternatives for development, acquisition targets and growth. Phynova is a 
public company listed on both the AIM and PLUS markets of the London Stock 
Exchange, as well as the US OTCQX market. 
 
 
"The worldwide growth potential of the functional foods and botanical medicine 
markets is remarkable," commented Stuart Bruck, Executive Chairman of London & 
Pacific. "We are delighted for this opportunity to provide strategic development 
advisory services to C&W and its client. Botanical health and functional foods 
have long been a part of mainstream healthcare in certain international markets, 
and are just beginning to hit their stride in Western healthcare markets. There 
is an enormous amount of market potential worldwide, and I am most pleased to 
have this 'ground floor' opportunity." 
 
 
About London & Pacific Healthcare, Inc.: 
With offices in Los Angeles, London and Mumbai, London & Pacific Healthcare, 
Inc. is a specialist in the development, management of healthcare companies and 
organizations, worldwide. The Company's website address 
is www.lphealthcare.com. 
 
 
About City & Westminster Corporate Finance, LLP: 
City & Westminster Corporate Finance, LLP is an independent corporate finance 
and business advisory firm and corporate adviser on PLUS Markets, wholly owned 
by its members and authorized and regulated by the Financial Services Authority 
in the United Kingdom. C&W's website address is www.city-westminster.com." 
 
 
For further information, please contact: 
 
 
+--------------------------------------------+----------------------------+ 
| Phynova Group PLC                          |        [phone] | 
+--------------------------------------------+----------------------------+ 
| Steve Harris (Non-Executive Chairman)      |                            | 
+--------------------------------------------+----------------------------+ 
| Robert Miller (Chief Executive Officer)    |                            | 
+--------------------------------------------+----------------------------+ 
|                                            |                            | 
+--------------------------------------------+----------------------------+ 
 
 
Notes to Editors: 
 
 
About Phynova 
Phynova is a UK company developing new prescription pharmaceuticals derived from 
plants used in Chinese medicines. The Company is focused on viral and bacterial 
diseases, metabolic diseases and cancer. Phynova's lead product for hepatitis C 
has now completed a Phase I/II trial in the US. One further product, for 
post-operative ileus, is targeted for entry to the clinic and there are a 
further four products in preclinical development. 
 
 
For further information please visit www.phynova.com. 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 NRAEALKXFANNEFE